SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-107897
Filing Date
2024-09-18
Accepted
2024-09-18 17:32:35
Documents
2
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1566
2 EX-24 dnth-ex24.htm EX-24 9210
  Complete submission text file 0000950170-24-107897.txt   12365
Mailing Address C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR NEW YORK NY 10036
Business Address
Romano Steven J. (Reporting) CIK: 0001639860 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38541 | Film No.: 241308406

Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)